IRadimed Corp. (IRMD)
95.24
-0.76
(-0.79%)
USD |
NASDAQ |
Jun 11, 12:18
IRadimed EPS Diluted (Quarterly) : 0.4521 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4521 |
| December 31, 2025 | 0.5004 |
| September 30, 2025 | 0.4336 |
| June 30, 2025 | 0.4498 |
| March 31, 2025 | 0.3655 |
| December 31, 2024 | 0.4018 |
| September 30, 2024 | 0.3952 |
| June 30, 2024 | 0.3842 |
| March 31, 2024 | 0.3244 |
| December 31, 2023 | 0.3564 |
| September 30, 2023 | 0.3979 |
| June 30, 2023 | 0.3285 |
| March 31, 2023 | 0.2685 |
| December 31, 2022 | 0.2908 |
| September 30, 2022 | 0.2713 |
| June 30, 2022 | 0.2566 |
| March 31, 2022 | 0.1965 |
| December 31, 2021 | 0.3081 |
| September 30, 2021 | 0.2044 |
| June 30, 2021 | 0.1171 |
| March 31, 2021 | 0.1108 |
| December 31, 2020 | 0.0509 |
| September 30, 2020 | 0.086 |
| June 30, 2020 | -0.1749 |
| March 31, 2020 | 0.1431 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2626 |
| September 30, 2019 | 0.1994 |
| June 30, 2019 | 0.1708 |
| March 31, 2019 | 0.1509 |
| December 31, 2018 | 0.1396 |
| September 30, 2018 | 0.1968 |
| June 30, 2018 | 0.11 |
| March 31, 2018 | 0.07 |
| December 31, 2017 | 0.02 |
| September 30, 2017 | 0.02 |
| June 30, 2017 | 0.03 |
| March 31, 2017 | -0.02 |
| December 31, 2016 | 0.10 |
| September 30, 2016 | 0.13 |
| June 30, 2016 | 0.19 |
| March 31, 2016 | 0.19 |
| December 31, 2015 | 0.19 |
| September 30, 2015 | 0.15 |
| June 30, 2015 | 0.15 |
| March 31, 2015 | 0.12 |
| December 31, 2014 | 0.02 |
| September 30, 2014 | 0.02 |
| June 30, 2014 | 0.11 |
| March 31, 2014 | 0.0503 |
| March 31, 2013 | 0.0618 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.095 |
| IDEXX Laboratories, Inc. | 3.474 |
| Masimo Corp. | 1.070 |
| Neogen Corp. | -0.0781 |
| QuidelOrtho Corp. | -1.346 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.818M |
| Revenue (Quarterly) | 21.98M |
| Total Expenses (Quarterly) | 16.16M |
| Enterprise Value | 1.171B |
| Gross Profit Margin (Quarterly) | 76.50% |
| Profit Margin (Quarterly) | 26.47% |
| Earnings Yield | 1.93% |
| Operating Earnings Yield | 2.28% |
| Normalized Earnings Yield | 1.928 |